Susanna Sorrentino, MD
Dr. Susanna Sorrentino, a specialist in genetics, has joined the UNLV Medicine Pediatric Center. She comes to Southern Nevada from California, where for two years she was the Valley Children’s Hospital Director of the Cancer Genetics Program and Director of the Cardio Genetics Program. Valley Children’s is an educational affiliate of Stanford University.
Dr. Sorrentino sees patients and teaches medical students/residents. She serves as the section chief for genetics and is an assistant professor of pediatrics with the UNLV School of Medicine.
A 2004 graduate of the Ross University School of Medicine in the West Indies, she completed a residency in pediatrics at Winthrop University Hospital in Mineola, NY in 2007. In 2009 she completed a fellowship in genetics and genomic sciences at Mount Sinai Medical Center in New York City.
Dr. Sorrentino has also served for two years as the Children’s Hospital Los Angeles Director of the Rare and Undiagnosed Disease Program. There she provided inpatient and outpatient genetic consultations for pediatric patients dealing with challenges that included genetic syndromes, inborn errors of metabolism and cancer.
During her 10-year career, Dr. Sorrentino has also worked in private practice and as a hospitalist. She has evaluated patients in both neonatal and pediatric intensive care units as well as provided consultations for expectant parents with concerns for birth defects or a family history of a genetic condition.
An accomplished researcher, she has conducted studies on genetic conditions and her work has appeared in distinguished publications, including the Journal of Medical Genetics.
- “OTX2 Mutations Contribute to the Otocephaly-Dysgnathia Complex”Chassaing, N*, Sorrentino, S* ET. Al
J Med Genet. 2012 Jun; 49(6): 373-9. PMID: 22577225.
- “Compound Heterozygous Variants in the LARP7 Gene as a Cause of Alazami Syndrome in a Caucasian Female with Primordial Dwarfism and Developmental Disability”Ling, T and Sorrentino, S. Am J Med Genet A. 2016 Jan; 170(1): 217-9. Epub 2015 Sep 16. PMID: 26374271.
- “De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism.”Tanaka AJ, Cho MT, Willaert R Retterer K, Zarate YA, Bosanko K, Stefans V, Oishi K, Williamson A, Wilson GN, Basinger A, Barbaro-Dieber T, Ortega L, Sorrentino S, Gabriel MK, Anderson IJ, Sacoto MJG, Schnur RE, Chung WK, Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6). PMID: 29162653.